Marianniz Diaz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Marianniz Diaz has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
Ana Victoria Casadesus
Center of Molecular Immunology, P.O. Box 16040, 216 St., Havana, Cuba
1 shared publication- Beatriz Perez Masson
Center of Molecular Immunology, P.O. Box 16040, 216 St., Havana, Cuba
1 shared publication Belinda Sanchez Ramirez
Center of Molecular Immunology, P.O. Box 16040, 216 St., Havana, Cuba
1 shared publication- Briandy Fernandez-Marrero
Department of Biological Sciences, College of Science, The University of Texas at El Paso, El Paso, TX 79968, USA
1 shared publication Carmen Valenzuela
Institute of Cybernetics, Mathematics and Physics, Havana 10400, Cuba
1 shared publicationCheng Fang
Shanghai Fenglin Glycodrug Promotion Center, Shanghai 200032, China
1 shared publication
Latest Publications
- Open Access
- 8 December 2021
- Published by Royal Society of Chemistry (RSC) in RSC Chemical Biology
- Vol. 3 (2) , 242-249
A COVID-19 vaccine candidate composed of the SARS-CoV-2 RBD dimer and Neisseria meningitidis outer membrane vesicles
Soberana01 is composed of the SARS-CoV-2 dimeric RBD and Neisseria meningitidis outer membrane vesicles (OMVs) adsorbed on alum. This vaccine induces a potent neutralizing immune response and shows potential against SARS-CoV-2 variants of concern.
- 8 December 2021
- Published by Royal Society of Chemistry (RSC) in RSC Chemical Biology
- Vol. 3 (2) , 242-249
Open AccessA COVID-19 vaccine candidate composed of the SARS-CoV-2 RBD dimer and Neisseria meningitidis outer membrane vesicles
Soberana01 is composed of the SARS-CoV-2 dimeric RBD and Neisseria meningitidis outer membrane vesicles (OMVs) adsorbed on alum. This vaccine induces a potent neutralizing immune response and shows potential against SARS-CoV-2 variants of concern.